Medical Research
Follow Medical Research in the Factlen app and get an alert when there is news. Get the app
- All Health
- Nutrition & Diet
- Supplements
- Mental Health
- Sleep
- Longevity
- Medicine
- Medications & Treatments
- Conditions & Diseases
- Hormones & Endocrinology
- Skincare
- Dental Health
- Family Health
- Children's Health
- Men's Health
- Women's Health
- Aging & Geroscience
- Biohacking
- Alternative Medicine
- Public Health
- Medical Research
- Preventive Wellness
- Healthy Habits
Small Cell Lung Cancer
Dual-Targeted Therapy Pumitamig and Elfetabart Drozuntecan Reaches 90% Response Rate in Early-Stage Small Cell Lung Cancer Trial
6 sources · 32d ago
AI in Biology
Insilico Medicine Releases Open-Source AI Toolkit for Aging Biology, Outperforming Frontier Models
3 sources · 31d ago
IgA Nephropathy
Two-Year Phase 3 Data Confirms Trutakna's Efficacy in IgA Nephropathy, Intensifying Race for Full Approval
5 sources · 30d ago
More in Medical Research
Gene TherapyFDA Approval
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
Biotech Industry 45%Regulatory Authorities 35%Clinical Synthesis 20%
Oncology CareClinical Review
Structured Exercise Cuts Cancer Mortality by 23% and Recurrence by 17%, Systematic Review Finds
Clinical Researchers 40%Oncology Care Providers 30%Patient Advocacy Groups 30%
NeuroprostheticsMedical Breakthrough
New Brain Implant Decodes Speech and Body Language Simultaneously for Paralysis Patients
Clinical Researchers 50%Patient Advocates 35%Neuroethics Scholars 15%
Research BriefClinical Trial Design
How Intention-to-Treat Analysis Preserves Randomization and Prevents Selection Bias
Methodologists & Regulators 45%Clinical Practitioners 30%Biomedical Researchers 25%
ExplainerProtein Folding
The GroEL/GroES Double-Chambered Barrel: How ATP Hydrolysis Folds Misfolded Polypeptides
Active Annealing Advocates 50%Passive Cage Proponents 50%
Lipid ManagementTrial Results
First Dual-Gene RNA Therapy Cuts LDL Cholesterol by 54% and Triglycerides by 73% in Early Trial
Cardiovascular Researchers 40%Clinical Practitioners 35%Biotech Analysts 25%
GLP-1 ResearchClinical Finding
Semaglutide Linked to 40% Reduction in Asthma Attacks and Fewer COPD Flare-ups in Real-World Study
Pulmonology Researchers 40%Clinical Practitioners 35%Health Economists 25%
Lung CancerTrial Results
Immunotherapy Gotistobart Nearly Doubles Overall Survival in Previously Treated Squamous Non-Small Cell Lung Cancer
Clinical Oncologists 50%Immunology Researchers 30%Industry Analysts 20%
Research BriefCellular Aging
How Senolytics Selectively Induce Apoptosis in Senescent Cells to Reverse Tissue Dysfunction
Clinical Researchers 45%Longevity Optimists 30%Biological Skeptics 25%
Targeted TherapyClinical Trial Results
Updated 8-Year Data Shows Osimertinib Reduces Risk of Death by 47% in Early-Stage EGFR-Mutated Lung Cancer
Clinical Researchers 50%Pharmaceutical Industry 30%Patient Care Advocates 20%
ExplainerCholesterol Metabolism
How HMG-CoA Reductase Inhibition Upregulates LDL Receptors to Clear Cholesterol
Clinical Cardiologists 40%Molecular Biologists 30%Pharmacologists 30%
ExplainerInflammasome Biology
How Monosodium Urate Crystals Activate the NLRP3 Inflammasome to Initiate the Acute Gout Flare
Immunologists & Cell Biologists 40%Metabolic Disease Researchers 30%Clinical Rheumatologists 30%
ExplainerEvidence Quality
The Systematic Review and Meta-Analysis Apex: How the Hierarchy of Evidence Ranks Research Quality
Methodological Purists 40%Pragmatic Clinicians 35%Framework Evaluators 25%
ExplainerPain Neurobiology
How Glial Cell Activation Sustains Chronic Pain by Upregulating NMDA Receptor Activity in the Spinal Cord
Neuroimmunology Focus 35%Synaptic Plasticity Focus 35%Astrocyte Regulation Focus 30%
Targeted TherapyTrial Results
B7-H3 Targeted Therapy Risvutatug Rezetecan Reduces Risk of Death by 54% in Relapsed Small-Cell Lung Cancer
Clinical Oncologists 40%Global Regulatory Analysts 30%Pharmaceutical Industry Competitors 30%
Cardiac RegenerationMedical Breakthrough
Researchers Show Human Heart Muscle Cells Can Regrow After Heart Attack
Regenerative Medicine Researchers 40%Clinical Cardiologists 30%Translational Scientists 30%
Regenerative MedicineTrial Results
Regeneration-Inducing Medicine Redasemtide Closes Refractory Ulcers in Phase 2 Trial, Misses Stroke Endpoint
Platform Optimists 40%Clinical Skeptics 40%Editorial Synthesis 20%
Spinal Muscular AtrophyTreatment Approval
FDA Approves First Muscle-Targeted Treatment ISEMBYLD for Spinal Muscular Atrophy
Patient Advocacy Organizations 40%Clinical Researchers 30%Biotech Analysts 30%
ExplainerCRISPR Mechanics
How a 20-Nucleotide Guide RNA Sequence Directs the Cas9 Nuclease to a Specific Genomic Locus
Structural Biologists 35%Clinical Geneticists 35%Bioengineers 30%
Bladder CancerClinical Trial Results
Oral Pill Dabogratinib Shows 79% Response Rate in Intermediate-Risk Bladder Cancer Trial
Oncology Researchers 40%Clinical Urologists 35%Biotech Industry Analysts 25%
Brain Development
How Metabolism and Physical Touch Guide the Stem Cells That Build the Human Brain
Developmental Neurobiologists 40%Metabolic Researchers 30%Clinical & Psychiatric Researchers 30%
ExplainerGastric Health
How Proton Pump Inhibitors Irreversibly Block the H+/K+-ATPase Pump and the Evidence for Long-Term Risk
Medical Consensus 40%Deprescribing Advocates 35%Pharmacological Researchers 25%
Genomics AITool Release
DeepMind Unveils AlphaGenome Atlas to Predict the Effects of 9 Billion DNA Variants
Computational Biologists 40%Translational Researchers 40%Cloud Infrastructure Providers 20%
Lung CancerClinical Trial Results
Tarlatamab and Durvalumab Combination Achieves Overall Survival Benefit in First-Line Extensive-Stage Small Cell Lung Cancer
Clinical Oncologists 40%Pharmaceutical Developers 40%Market Analysts 20%
COPD TreatmentClinical Trial Results
First Biologic Tozorakimab Reduces COPD Exacerbations Across All Eosinophil Levels in Phase 3 Trials
Clinical Researchers 40%Pharmaceutical Industry 35%Medical News Analysts 25%
ExplainerCausal Inference
The d-Separation Rule: How Directed Acyclic Graphs Identify and Block All Sources of Causal Bias
Clinical Epidemiologists 35%Machine Learning Theorists 35%Applied Statisticians 30%
ExplainerPlacebo Science
How Naloxone Proves the Placebo Effect Is a Measurable Biochemical Response
Biochemical Mechanists 40%Clinical Translators 35%Behavioral & Social Theorists 25%
Drug DiscoveryMilestone Approval
China Approves Mprosevir, the First Class 1 Innovative Drug Developed With AI Assistance
AI Integration Advocates 60%Regulatory Traditionalists 40%
ExplainerCausal Inference
The Three Criteria a Variable Must Meet to Be a Confounder in Causal Inference
Classical Epidemiologists 35%Causal Inference Statisticians 35%Clinical Researchers 30%
ExplainerProbability Theory
Brier Score Decomposition Splits Forecast Error into Reliability and Resolution
Statistical Purists 40%Clinical Risk Modelers 35%Machine Learning Pragmatists 25%
ExplainerStatistical Methods
Alpha (α), Beta (β), and Power: How Type I and Type II Errors Define Statistical Significance and Test Sensitivity
Classical Frequentists 40%Reform Advocates 30%Statistical Educators 30%
Menopause TimingRisk Stratification
Early Menopause Linked to Faster Brain Aging and Earlier Alzheimer's Onset in Women
Neurological Researchers 40%Clinical Practitioners 35%Patient Advocacy Groups 25%
Drug SafetyClinical Finding
Long-Term Tadalafil Prescriptions Linked to Modest Glaucoma Increase in 74,000-Patient Review
Urological Prescribers 40%Ophthalmological Researchers 40%Patient Advocacy 20%
ExplainerReceptor Pharmacology
How CBD and THC Differ at the CB1 Receptor: The Mechanics of Allosteric Modulation
Pharmacological Researchers 40%Clinical Practitioners 35%General Science Reference 25%
ExplainerGut-Brain Axis
Why the Gut, Not the Brain, Is the Body's Primary Serotonin Factory
Microbiome Researchers 40%Gastroenterologists 30%Neurocentric Psychiatrists 30%
ExplainerLipid Science
Reverse Cholesterol Transport: Why Raising HDL Levels Fails to Prevent Heart Attacks
Lipidologists 40%Preventive Cardiologists 35%Pharmaceutical Researchers 25%
Lipoprotein(a)Clinical Trial Results
Lp(a)-Lowering Drug Pelacarsen Fails to Reduce Major Cardiovascular Events in Phase 3 Trial
Clinical Cardiologists 40%Pharmaceutical Analysts 30%Drug Developers 30%
ExplainerStatistical Power
How Effect Size, Alpha, and Power Interlock to Determine Experimental Sample Size
Clinical Methodologists 40%Frequentist Data Scientists 40%Bayesian Critics 20%
Post-MI CareClinical Guidelines
Pooled Analysis Confirms Beta-Blockers Can Be Safely Discontinued in Stable Post-Heart Attack Patients
Clinical Trial Investigators 45%Conservative Cardiologists 30%Patient Quality-of-Life Advocates 25%
KRAS InhibitorsTrial Results
Pan-KRAS Inhibitor Daraxonrasib Shrinks Tumors in 30% of Metastatic Lung Cancer Patients
Broad-Spectrum Advocates 40%Precision Oncology Traditionalists 35%Clinical Pragmatists 25%
ExplainerMedical Statistics
Decoding Medical Statistics: Why Relative Risk Reduction Overstates Treatment Benefits
Evidence-Based Medicine Advocates 50%Clinical Researchers 50%
Psychedelic MedicineStudy Findings
Psilocybin Prevents Chemotherapy Nerve Damage in Mice, Preserving Cancer Treatment Efficacy
Medical Researchers 50%Oncology Practitioners 30%Clinical Skeptics 20%
ExplainerKidney Disease Staging
The GFR and Albuminuria Two-Axis System for Staging Chronic Kidney Disease
Clinical Guideline Authors 40%Primary Care Providers 30%Cardiovascular Specialists 30%
Leukemia TreatmentClinical Trial Results
Less-Intensive Drug Combination Outperforms Standard Chemotherapy in Acute Myeloid Leukemia Trial
Clinical Researchers 40%Patient Quality-of-Life Advocates 35%Standard-of-Care Proponents 25%
Alexander DiseaseTreatment Approval
FDA Approves First Disease-Modifying Drug for Rare Neurological Disorder Alexander Disease
Clinical Neurologists 40%Pharmacy & Logistics Teams 30%Patient Families 30%
Vaccine TechClinical Milestone
GSK's mRNA Flu Vaccine Beats Standard Shots in Phase 2, Advances to Phase 3 Trials
Public Health Advocates 40%Biotech Industry Analysts 30%Clinical Practitioners 30%
Per page